2019

Ackermann C, Smits M, Woost R, Eberhard JM, Peine S, Kummer S, Marget M, Kuntzen T, Kwok WW, Lohse AW, Jacobs T, Boettler T, Schulze Zur Wiesch J.

HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules.
Sci Rep. 2019 Jul 23;9(1):10624:

Karimzadeh H, Kiraithe MM, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze Zur Wiesch J, Budeus B, Hoffmann D, Wedemeyer H, Cornberg M, Krawczyk A, Rashidi-Alavijeh J, Rodríguez-Frías F, Casillas R, Buti M, Smedile A, Alavian SM, Heinold A, Emmerich F, Panning M, Gostick E, Price DA, Timm J, Hofmann M, Raziorrouh B, Thimme R, Protzer U, Roggendorf M, Neumann-Haefelin C.

Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8 T Cells and Evolve at the Population Level.
“ Gastroenterology. 2019 May;156(6):1820-1833.

Sagebiel AF, Steinert F, Lunemann S, Körner C, Schreurs R.C.E, Altfeld M, Perez D, Reinshagen K & Bunders MJ.

Tissue-resident Eomes+ NK cells are the major innate lymphoid cell population in human infant intestine.
Nature Communications, 2019 Feb 28

Landahl J, Bockmann JH, Scheurich C, Ackermann C, Matzat V, Heide J, Nuurei T, D’Antonio G, von Felden J, Sette A, Peine S, Lohse AW, Luetgehetmann M, Marget M, Sidney J, Schulze Zur Wiesch J.

Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status.
J Infect Dis. 2019 Jan 29;219(4):568-577.

Piecha F, Gänßler JM, Jordan S, Ergen C, Ittrich H, Kluwe J, Pischke S, Lohse AW, Schulze Zur Wiesch J.

Transjugular Intrahepatic Portosystemic Shunt: A Possible Risk Factor for Direct-Acting Antiviral Treatment Failure in Patients With Hepatitis C?
Hepatol Commun. 2019 Mar 18;3(5):614-619

Muscate F, Stetter N, Schramm C, Schulze Zur Wiesch J, Bosurgi L, Jacobs T.

HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage.
Front Immunol. 2018 Nov 13;9:2611.